News
Trio of Bristol scientists win prestigious Royal Society of Chemistry prizes
8 June 2021
Professor Jonathan Reid, Professor Carmen Galan, and Professor Michael Ashfold, who are all based in the School of Chemistry, have been named the winners of three prizes from the Royal Society of Chemistry, celebrating the most exciting chemical science taking place today.
- Professor Imre Berger elected Fellow of prestigious Academy of Medical Sciences 18 May 2022 Imre Berger, Professor of Biochemistry and Chemistry and Director of Bristol’s Max Planck Centre for Minimal Biology has been elected as a Fellow of the Academy of Medical Sciences for his outstanding contributions to biomedical science and notable discoveries during the COVID-19 pandemic.
- Amounts of aerosol from vigorous exercise and conversational speaking are similar, finds first study to examine exhaled aerosol emission rates during exercise 19 April 2022 Vigorous exercise does not produce significantly more respiratory particles than speaking, but high-intensity exercise does, finds new University of Bristol-led research. The study, published in Communications Medicine, is the first to measure exhaled aerosols generated during exercise, to help inform the risk of airborne viral transmission of SARS-CoV-2 for indoor exercise facilities and sporting and physical group activities.
- BBSRC sLoLa Grant to Pioneer Biological Electronics 6 April 2022 Professor Adrian Mulholland, Dr Tom Oliver and Dr Sofia Oliveira from the School of Chemistry have been awarded a 5-year £4.9 m Strategic Longer and Larger (sLoLa) grant by BBSRC entitled “Creating and comprehending the circuitry of life: precise biomolecular design of multi-centre redox enzymes for a synthetic metabolism”.
- New research shows virus plays ultimate game of ‘hide and seek’ with immune system 6 April 2022 SARS-CoV-2-infected individuals could have different variants hidden in different parts of the body.
- Making the invisible visible: tracing the origins of plants in West African cuisine 17 January 2022 A team of scientists, led by the School of Chemistry, University of Bristol, in co-operation with colleagues from Goethe University, Frankfurt, has uncovered the first insights into the origins of West African plant-based cuisine, locked inside pottery fragments dating back some 3,500 years ago.
- Source of large rise in emissions of unregulated ozone destroying substance identified 16 December 2021 New research, led by the School of Chemistry, University of Bristol and Peking University, has discovered that emissions coming from China of the ozone-destroying chemical, dichloromethane, have more than doubled over the last decade.
- Pioneering measurement techniques on display at COP26 hold key to effectively combat climate change 10 November 2021 Leading atmospheric scientists are measuring emissions of the most dangerous greenhouse gases at COP26 and sharing them live online to highlight how rigorous measurement and detailed data reporting are essential in the fight against climate change.
- Collaborative COVID-19 lockdown effort delivers major boost for vaccine innovation in Bristol 21 October 2021 Faster vaccine development could be a step closer thanks to £4 million investment to Imophoron Ltd, a Bristol University biotech start-up developing a novel, next generation rapid-response vaccine platform called ADDomer™. Imophoron will use the investment to bring ADDomer vaccines to clinical stage, initially targeting three viruses, RSV (respiratory syncytial virus), COVID-19, and mosquito-borne Chikungunya.
- Dr Colin Western, 1957 - 2021 7 October 2021 Dr Colin Western, Reader in Chemistry, died on 21st September 2021. Professors Andrew Orr-Ewing and Mike Ashfold offer this appreciation.
- Major advance in race for SARS-CoV-2 inhibitor drugs 30 September 2021 A new advance towards the development of drugs specifically designed to inhibit a key SARS-CoV-2 enzyme is reported in the Royal Society of Chemistry's leading journal, Chemical Science. The international team, led by scientists from the Universities of Oxford and Bristol, has designed new peptide molecules and shown that they block (inhibit) the virus’s main protease [Mpro] - a prominent SARS-CoV-2 drug target.